Summary. The existence of the enzyme prostaglandin E-2-9-ketoreductase which can convert prostaglandin E-2 to prostaglandin F-2\g=a\was 
Introduction
The prostaglandins E-2 (PGE-2) and F-2a (PGF-2a) have opposing effects on steroid metabolism by reproductive tissues. It is now well established that PGE-2 is a potent stimulator of steroidogenesis in ovarian tissues and, in addition, the steroidogenic action of the compound mimics that of luteinizing hormone (LH) in that activation of the adenylate cyclase system is involved (Kuehl, Humes, Tarnoff, Cirillo & Hamm, 1970; Marsh & LeMaire, 1974) . PGF-2ais now believed to be the uterine luteolytic agent in most species except primates (see Horton & Poyser, 1976 , for review). Human luteal function appears to be independent of uterine control since neither hysterectomy (Beling, Marcus & Markham, 1970) nor congenital absence of Fallopian tubes, uterus and vagina (Fraser, Baird, Hobson, Michie & Hunter, 1973 ) disrupt cyclic ovarian function. PGF-2a in vitro, however, in cultured human granulosa cells (McNatty, Henderson & Sawers, 1975) , or directly injected into the human ovary (Korda, Shutt, Smith, Shearman & Lyneham, 1975) reduces progesterone secretion, suggesting a possible intraovarian role for in man. The synthesis of both PGE-2 and PGF-2a by human luteal tissue in vitro has been demonstrated (Challis et al., 1976; McDougall, Maule Walker & Watson, 1977) . In view of the opposing effects of the two prostaglandins, plus the fact that PGE-2 antagonizes the effects of PGF-2a in human granulosa cell cultures (McNatty et al, 1975) , an enzyme, or enzymes, which would interconvert them in ovarian tissue could be of considerable importance in controlling ovarian function. The existence of the enzymes PGE-2-9-ketoreductase and PGF-2a-9-hydroxydehydrogenase has been reported for several animal tissues including kidney (Dunn & Hood, 1977) , testis (Thuy & Carpenter, 1978) and liver (Hensby, 1975) , and although postulated in ovarian tissues (Demers, Behrman & Greep, 1973) , their presence in ovaries has not yet been shown. Ovarian synthesis of PGE-2 and PGF-2a has also been reported in species in which PGF-2a is luteolytic, including pig (Patek & Watson, 1976) , cow (Shemesh & Hansel, 1975) and guinea-pig (Sharma, Wilson & Pugh, 1976) , and although uterine PGF-2a in these species is of prime importance, there may well be a contribution to luteolysis from ovarian PGF-2afor which interconversion of PGE-2 and PGF-2a would be important.
The purpose of the present investigation was to determine whether enzymes exist which can interconvert PGE-2 and PGF-2a in human, pig and rat ovarian tissues.
Materials and Methods
All chemicals were of AR grade and solvents were further purified by distillation in an allglass system. [l, 2, 6, Ci/mmol), [5,6,11,14,15(n) -3H]prostaglandin B-2 (sp. act. 115 Ci/mmol), [5,6,8,11,12,14,15(n) -3H]-prostaglandin E-2 (sp. act. 160 Ci/mmol) and [5,6,8,1 l,12,14,15(n) (Seaton, Lusty & Watson, 1976 (Channing & Kammerman, 1973) . The ages of the corpora lutea were assessed by visible and histological examination as previously described (Watson & Leask, 1975) (1976) .
Incubations
The superfusion technique was that previously described and consists of pumping Medium 199, or Medium 199 containing test substances, through a known weight of luteal tissue slices (0-4 mm thick, 100 mg) or halved follicles (8-10 mm diameter), with the effluent being collected for selected time intervals. The whole system was completely closed and maintained at 4°C to ensure sterility. The input medium was heated to 37°C by passage through glass coils in a water bath at 37°C which also contained the superfusion chambers. The tissues were superfused with Medium 199 alone for 3 h, after which PGE-2 or PGF-2a was present in the superfusion medium for the next 3 h and superfusion was then continued for a further 12 h with medium alone. Control incubations contained no prostaglandins and additional incubations were also carried out in the presence of indomethacin, an inhibitor of prostaglandin synthesis. The indomethacin was dissolved in the minimum amount of ethanol and made up to the appropriate concentration with Medium 199.
Incubations with subcellular fractions for the radiotracer and radioimmunoassay experiments were carried out in potassium phosphate buffer (0-1 m, pH 7-4) containing NADPH (0-15 mM), glucose-6-phosphate (3 · 5 mM), glucose-6-phosphate dehydrogenase (2 units), dithiothreitol (0-1 mM) and PGE-2 (7 pM). Incubations were carried out with or without [3H]PGE-2 (0-5 pCi). Each incubation contained dialysed supernatant (0-7 ml) to a final volume of 1 ml. Control incubations consisted of the above incubation mixtures minus NADPH. Incubations were carried out at 37°C for 1 h, using a shaking water bath, and were terminated by acidification with citrate buffer (pH 4-0).
Radioimmunoassays
Prostaglandin F-2a was measured by the double-antibody radioimmunoassay procedure previously described . In these experiments, the inter-and intraassay coefficients of variation were 6-1 and 4-3% respectively. Blank values were consistently <5 pg PGF-2a/ml medium and were therefore disregarded.
Prostaglandin E-2 was assayed as prostaglandin B-2 equivalents, the conversion of PGE-2 to PGB-2 being carried out by the method of Dozois & Thompson (1974) . Efficiency of conversion averaged 86 ± 4-6% (mean ± s.e.m., = 1). Conversion was carried out no later than the day following the experiment. Extraction of the PGE-2 was achieved by acidifying volumes of superfusate or incubation medium with equal volumes of citrate buffer (pH 4-0) and extracting twice with two volumes of redistilled diethyl ether. The dried extracts were then converted and PGB-2 was estimated by radioimmunoassay, using the method described for PGF-2a by Patek & Watson (1976) , except that the antibody used had been raised against PGB-2-bovine serum albumin. The inter-assay coefficient of variation was 7-4% and the intra-assay coefficient of variation, after conversion, was 6-1%. Blank values were consistently <5 pg/ml medium as were unconverted samples, indicating the absence of endogenous PGB- 1(B) . In all tissues, each prostaglandin gave rise to significantly (P < 0-01) increased secretion of the other relative to control incubations. Since this increased secretion also occurred in the incubations containing indomethacin, the increased secretion could not be due to synthesis. An increase due solely to cross-reactivity of prostaglandins in the radioimmunoassays can also be ruled out because medium containing 10 pg PGE-2/ml gave, on analysis, a value of 2-3 ± 0-3 ng (s.e.m.) PGF-2a/ml (n = 6), and medium containing 10 pg PGF-2a/ml gave 0-3 ± 0-1 ng PGE-2/ml (n = 6). These values were significantly lower (P < 0-01) than those obtained when tissue was present (Table 1) . These results suggest the existence of an enzyme, or enzymes, which can interconvert PGE-2 and PGF-2a in ovarian tissues. experiments.
In order to verify the results of tracer studies with the supernatant, aliquots of supernatant were also incubated with appropriate amounts of non-radioactive PGE-2 and the amounts of PGF-2a produced were monitored by radioimmunoassay. The results are shown in Table 2 and provide a reliable means of measuring the conversion of PGE-2 to PGF-2a which increased in the order: pig < human < rat.
Discussion
Many of the pharmacological actions of PGE-2 and PGF-2a differ both qualitatively and quantitatively; e.g. PGE-2 is a bronchodilator whereas PGF-2a is a bronchoconstrictor (Sweatman & Collier, 1968) , PGE-2 and endoperoxides stimulate kidney renin synthesis while PGF-2a inhibits renin synthesis (Dunn & Hood, 1977) , and PGE-2 is luteotrophic in most reproductive tissues whereas PGF-2a is luteolytic (Kuehl et al, 1970; Horton & Poyser, 1976) . In addition, PGE-2 antagonizes the effects of PGF-2a in reproductive tissues. An enzyme or enzymes which could interconvert PGE-2 and PGF-2a in particular mammalian tissues could therefore play a very important role in the mechanism of action of these prostaglandins. The presence of an interconverting enzyme in ovarian tissues, although postulated by Demers et al (1973) , has not to date been demonstrated although it does appear to be fairly widespread in other animal tissues including kidney (Dunn & Hood, 1977) , testis (Thuy & Carpenter, 1978) and liver (Hensby, 1975) .
The initial results (Table 1 ) in the present study were obtained during in-vitro superfusion experiments to study the roles of PGE-2 and PGF-2a on the processes of ovulation and luteolysis in man and pig. It was always observed that addition of either PGE-2 or PGF-2a to the superfusing medium gave rise to increased secretion of the other prostaglandin which suggested the presence of an enzyme(s) that could interconvert PGE-2 and PGF-2a
In tissues other than the ovary, the PGE-2-9-ketoreductase enzyme has been the most studied although it has not been shown whether the action of this enzyme is reversible or, as proposed by Pace-Asciak (1975) , a separate 9-hydroxydehydrogenase enzyme exists. The 9-ketoreductase enzyme has been reported to be present mainly in the cytosol subcellular fraction (supernatant) of other tissues and further experiments in the present study concentrated on studying this enzyme in such fractions of ovarian tissues. The conversion of PGE-2 to PGF-2a by ovarian supernatant (dialysed to remove endogenous prostaglandin) has been demonstrated and shown to be NADPH-dependent. Further, preliminary data indicated that the conversion could be reversed if PGF-2a was used as substrate and NADP as cofactor, which tends to suggest a single enzyme.
In the human ovary, the degree of conversion of PGE-2 to PGF-2a in corpora lutea was substantial (52%) and this PGF-2a may be of considerable importance as a proportion of the total material secreted by the corpus luteum (Challis et al, 1976; . The activity of the stromal tissue which gave a 20% conversion of PGE-2 to PGF-2awas particularly interesting. This tissue is generally considered as being relatively inactive in the ovary, although Challis et al (1976) demonstrated that it synthesized both prostaglandins in vitro, and the present study demonstrates also that it contains the PGE-2-9-ketoreductase enzyme. Although no differences were noted in the degree of conversion on different days of the menstrual cycle, the data were from a limited study and a much larger group of patients will have to be studied to determine whether the activity of the enzyme varies during the cycle and what variables may influence it. The demonstration of the existence of the PGE-2-9-ketoreductase enzyme is, however, consistent with the theory of an intraovarian luteolytic role for PGF-2a. The possible control of PGE-2/PGF-2a ratios in vitro by the PGE-2-9-ketoreductase enzyme during the cycle may account for the repeated failure to induce early luteolysis with PGF-2a in women. More information is therefore required on variables which may influence the activity of the enzyme in ovarian tissues. Activation of the enzyme by kinins has been demonstrated in the kidney (Terragno, Malik, Nasjpetti, Terragno & McGiff, 1976) .
The degree of conversion of PGE-2 to PGF-2a in the pig (8%) was significantly less than that for human tissue. Such a result may have been anticipated on the basis that ovarian production of PGF-2a in the pig may not be so important because there is a uterine contribution to the demise of the corpus luteum (Anderson, 1966) . The nature of this uterine contribution remains obscure since it can be derived from the contralateral horn of the uterus for either ovary and is not therefore a local effect as in many other species. The fact that a systemic factor does exist argues against free PGF-2a, which would be destroyed in the lungs, although Krzymowski, Kotwica, Okrasa, Doboszynska & Ziecik (1978) have demonstrated that infusion of PGF-2a into the anterior uterine vein of pigs reduced cAMP concentration in the contralateral ovary. The pig corpus luteum is refractory to the luteolytic effect of exogenous PGF-2a until after Day 12 of the cycle (Diehl & Day, 1973) . The PGF-2a produced by the low conversion of PGE-2 observed in the present experiments would appear unlikely to make a significant contribution to luteolysis in the pig ovary, but it is possible that the PGE-2-9-ketoreductase enzyme can be activated by a uterine factor or, if indeed two enzymes do exist, that this factor can affect the relative activities of the two enzymes around Day 12 of the oestrous cycle.
The results obtained with rat ovarian tissue are difficult to interpret and to relate to events in vivo. In the PMSG-hCG-primed (pseudopregnant) rat, a functional corpus luteum is formed and uterine PGF-2a may be important in controlling the length of pseudopregnancy (Poyser, 1978) . On this basis it might have been anticipated that conversion levels of PGE-2 to PGF-2a would be low, whereas high conversion was in fact found. In the normal cyclic rat, however, functional corpora lutea are not formed and there may be no role of uterine PGF-2a in controlling cycle length. The present results could indicate that conversion of PGE-2 to PGF-2a may play a more important role in controlling pseudopregnancy than does uterine PGF-2rx or that administration of gonadotrophins may have had a stimulating effect on the activity of the PGE-2-9-ketoreductase enzyme. The latter possibility seems more likely since TSH is known to stimulate the activity of the PGE-2-9-ketoreductase enzyme in the thyroid (Friedman, Levasseur & Burke, 1976) . However, the rat results probably have less significance than those obtained for pig and man because of the use of hormone-treated animals.
The results of this study suggest that the enzyme PGE-2-9-ketoreductase exists in ovarian tissues, and that its activity varies from one species to another. The role of the enzyme in ovarian metabolism is uncertain but it is possible that in man prostaglandins may have an intraovarian luteolytic effect. Further studies are proposed to determine whether the activity of the enzyme varies during the oestrous and menstrual cycles and whether gonadotrophins and steroids can influence the activity of the enzyme.
